Literature DB >> 2215849

The serotonin 5-HT1D receptor: a progress review.

C Waeber1, P Schoeffter, D Hoyer, J M Palacios.   

Abstract

Most of the known neurotransmitters interact with more than one type of receptor. Some of them even dispose of receptor subtypes to exert their actions. Serotonin, far from being an exception to that, possesses at least 3 classes of receptors, which have all been reported to be heterogeneous, although convincing data only exist for the 5-HT1 class. This name has been proposed in 1979, two years before the introduction of 'A' and 'B' in the nomenclature to account for the observed heterogeneity of these sites. The 5-HT1C receptor subtype was first described in 1984 and the last member of the family, named 5-HT1D, was characterized in 1987. The pharmacological profiles, the signal transducing systems and the anatomical localizations, both at the regional and cellular levels, of all these subtypes have been investigated and possible functions have been proposed for each of them. Moreover, last and most definitive demonstration of the subtype individuality, the gene or complementary DNA coding for the 5-HT1A and 5-HT1C (and 5-HT2) receptors have been cloned and sequenced. Such data are still missing for 5-HT1D (and 5-HT1B) receptors, but will certainly be provided in the next few years. However and waiting for this decisive clue, the characterization of the 5-HT1D subtype leaves no doubt concerning its significance as a function 5-HT receptor. This review will concentrate on the characteristics of this subtype of 5-HT receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215849     DOI: 10.1007/bf00973745

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  79 in total

1.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

2.  Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain.

Authors:  R Quirion; J Richard
Journal:  Synapse       Date:  1987       Impact factor: 2.562

3.  Agonist-induced phosphoinositide hydrolysis in choroid plexus.

Authors:  P J Conn; E Sanders-Bush
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

4.  5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography.

Authors:  C Waeber; M M Dietl; D Hoyer; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

5.  5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization.

Authors:  D Hoyer; C Waeber; P Schoeffter; J M Palacios; A Dravid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

6.  Prosencephalic pathways related to the paleostriatum of the pigeon (Columba livia).

Authors:  S E Brauth; J L Ferguson; C A Kitt
Journal:  Brain Res       Date:  1978-05-26       Impact factor: 3.252

7.  A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex.

Authors:  D N Middlemiss; M E Bremer; S M Smith
Journal:  Eur J Pharmacol       Date:  1988-11-15       Impact factor: 4.432

8.  Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

9.  LY165163 and 8-OH-DPAT have agonist effects on a serotonin responsive muscle of Aplysia.

Authors:  J L Ram; M A Kreiman; D Gole
Journal:  Eur J Pharmacol       Date:  1987-07-09       Impact factor: 4.432

10.  Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.

Authors:  A Doenicke; J Brand; V L Perrin
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

View more
  15 in total

1.  5-HT1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes.

Authors:  A T Bruinvels; H Lery; J Nozulak; J M Palacios; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

2.  "5-HT1R" or 5-HT1D sites? Evidence for 5-HT1D binding sites in rabbit brain.

Authors:  D Hoyer; H Lery; C Waeber; A T Bruinvels; J Nozulak; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

3.  The effects of oral sumatriptan, a 5-HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man.

Authors:  S J Entwisle; P A Fowler; M Thomas; D J Eckland; S Lettis; M York; P S Freedman
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

4.  Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.

Authors:  J M Zgombick; L E Schechter; N Adham; S A Kucharewicz; R L Weinshank; T A Branchek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

5.  Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptor.

Authors:  P Bhalla; H S Sharma; T Wurch; P J Pauwels; P R Saxena
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Serotonergic influences on male sexual behavior of rhesus monkeys: effects of serotonin agonists.

Authors:  S M Pomerantz; B C Hepner; J M Wertz
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Evidence that the unilateral activation of 5-HT1D receptors in the substantia nigra of the guinea-pig elicits contralateral rotation.

Authors:  G A Higgins; C C Jordan; M Skingle
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

8.  [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.

Authors:  H P Nowak; C D Mahle; F D Yocca
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  Possible antidepressant dihydroergosine preferentially binds to 5-HT1B receptor sites in the rat hippocampus.

Authors:  D Muck-Seler; D Pericić
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.

Authors:  Katarina Varnäs; Christer Halldin; Håkan Hall
Journal:  Hum Brain Mapp       Date:  2004-07       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.